Abera Bioscience receives all required approvals for Phase 1 Clinical Trial of Ab-01.12 – recruitment initiated
Abera Bioscience AB (“Abera” or the “Company”) today announces that all formal approvals are now in place to conduct the Phase 1 clinical trial of



